Spartalizumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Spartalizumab Usage And Synthesis

Uses

Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC)[1].

References

[1] Jaume Capdevila, et al. PD-1 Blockade in Anaplastic Thyroid Carcinoma. J Clin Oncol. 2020 Aug 10;38(23):2620-2627. DOI:10.1200/JCO.19.02727

Spartalizumab(1935694-88-4)Related Product Information

• Plamotamab
• Ivicentamab
• Lymphocide
• Cergutuzumab Amunaleukin
• Ezabenlimab
• Keliximab
• Regavirumab
• Lupartumab
• Modotuximab
• Anrukinzumab